Institutional Ownership Crinetics Pharmaceuticals, Inc. (CRNX)
This table provides information about the institutional ownership of Crinetics Pharmaceuticals, Inc. (CRNX). We have compiled data on the 235 institutions that hold shares in the stock, with a total of 85.9 Million shares, which have been reported (via 13F filing form) to have a value of $2.68 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
American Century Companies Inc
Kansas City, MO |
May 13, 2025 Q1 2025 |
719,578
shares
|
$22.5 Million
0.02% of portfolio
|
Q1 2025
Added 50.76%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
May 14, 2025 Q1 2025 |
689,265
shares
|
$21.5 Million
0.02% of portfolio
|
Q1 2025
Reduced 31.27%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
May 15, 2025 Q1 2025 |
631,964
shares
|
$19.7 Million
3.92% of portfolio
|
Q1 2025
Added 2.42%
|
|
|
Bnp Paribas Asset Management Holding S.A.
|
May 13, 2025 Q1 2025 |
610,839
shares
|
$19.1 Million
0.05% of portfolio
|
Q1 2025
Added 6.04%
|
|
|
Cormorant Asset Management, LP
Boston, MA |
May 15, 2025 Q1 2025 |
600,000
shares
|
$18.7 Million
2.13% of portfolio
|
Q1 2025
Reduced 40.0%
|
|
|
Nuveen, LLC
Charlotte, NC |
May 12, 2025 Q1 2025 |
562,935
shares
|
$17.6 Million
0.01% of portfolio
|
Q1 2025
New holding
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
527,792
shares
|
$16.5 Million
0.01% of portfolio
|
Q4 2024
Added 2.64%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
May 15, 2025 Q1 2025 |
523,431
shares
|
$16.3 Million
2.46% of portfolio
|
Q1 2025
Added 1.36%
|
|
|
Sg Americas Securities, LLC
|
Apr 15, 2025 Q1 2025 |
522,266
shares
|
$16.3 Million
0.06% of portfolio
|
Q1 2025
Reduced 3.72%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
May 14, 2025 Q1 2025 |
514,809
shares
|
$16.1 Million
0.03% of portfolio
|
Q1 2025
Added 2.41%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
514,684
shares
|
$16.1 Million
0.0% of portfolio
|
Q1 2025
Added 1.91%
|
|
|
Goldman Sachs Group Inc
New York, NY |
May 09, 2025 Q1 2025 |
499,594
shares
|
$15.6 Million
0.0% of portfolio
|
Q1 2025
Reduced 30.73%
|
|
|
Candriam S.C.A.
|
May 14, 2025 Q1 2025 |
488,911
shares
|
$15.3 Million
0.11% of portfolio
|
Q1 2025
New holding
|
|
|
Fiera Capital Corp
Montreal, A8 |
May 07, 2025 Q1 2025 |
438,337
shares
|
$13.7 Million
0.06% of portfolio
|
Q1 2025
Reduced 3.66%
|
|
|
Qube Research & Technologies LTD
London, X0 |
May 15, 2025 Q1 2025 |
429,063
shares
|
$13.4 Million
0.02% of portfolio
|
Q1 2025
Added 95.45%
|
|
|
Voya Investment Management LLC
Atlanta, GA |
May 15, 2025 Q1 2025 |
358,535
shares
|
$11.2 Million
0.02% of portfolio
|
Q1 2025
Reduced 7.88%
|
|
|
Logos Global Management LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
350,000
shares
|
$10.9 Million
2.29% of portfolio
|
Q1 2025
New holding
|
|
|
Universal Beteiligungs Und Servicegesellschaft Mb H
Frankfurt Am Main, 2M |
May 06, 2025 Q1 2025 |
342,734
shares
|
$10.7 Million
0.02% of portfolio
|
Q1 2025
Added 2.37%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Feb 14, 2025 Q4 2024 |
325,276
shares
|
$10.2 Million
0.0% of portfolio
|
Q4 2024
Added 19.7%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
315,659
shares
|
$9.85 Million
0.0% of portfolio
|
Q1 2025
Reduced 55.4%
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
304,926
shares
|
$9.52 Million
0.0% of portfolio
|
Q1 2025
Added 29.6%
|
|
|
M&G PLC
London, X0 |
May 13, 2025 Q1 2025 |
281,822
shares
|
$8.8 Million
0.07% of portfolio
|
Q1 2025
New holding
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
265,495
shares
|
$8.29 Million
0.0% of portfolio
|
Q1 2025
Reduced 1.5%
|
|
|
Victory Capital Management Inc
|
May 02, 2025 Q1 2025 |
251,331
shares
|
$7.84 Million
0.01% of portfolio
|
Q1 2025
Reduced 10.7%
|
|
|
Prudential Financial Inc
Newark, NJ |
May 13, 2025 Q1 2025 |
242,875
shares
|
$7.58 Million
0.01% of portfolio
|
Q1 2025
Reduced 12.44%
|